Natco Pharma Share Price Surges 11%: Why Semaglutide Approval and 6x Volume Spike Triggered a Breakout
Synopsis: Natco Pharma Ltd (NSE: NATCOPHARM) shares surged over 11% to reach ₹918 on February 16, 2026, following the CDSCO approval to manufacture and market generic Semaglutide injection in India. The breakout was fueled by a massive 6.4x spike in trading volume and positive Q3 FY26 results showing a 14.3% YoY profit jump to ₹151.3 […]












